Increasing evidence has shown that sestrin2 can protect cells by reducing oxidative stress and apoptosis in diabetes, cancer, and neurodegeneration, most of which target mTOR as a downstream factor [26, 40]. The gene discussed is MTOR; the disease is cancer.